New COVID variant of concern before 2027?

Traders currently price "No" at 94% for "New COVID variant of concern before 2027?". The market has traded $245K in total volume and resolves Dec 31, 2026. **Trader consensus on no new COVID variant of concern before 2027 reflects sustained low-level circulation and the absence of any lineage meeting formal WHO or ECDC criteria for elevated concern.** As of mid-2026, global SARS-CoV-2 activity remains low and stable, with very low emergency department visits, test positivity around 1%, and wastewater signals showing only modest or localized increases. Dominant strains continue to be Omicron sublineages such as XFG.1.1 and related descendants, while monitored variants like BA.3.2 (sometimes called Cicada) and PQ.16.1.1 stay classified as variants under monitoring due to limited evidence of greater transmissibility, severity, or immune escape. No lineage has triggered reclassification to variant of interest or concern in recent months, consistent with the virus evolving within established patterns rather than producing abrupt shifts. Continued genomic surveillance and low overall case volumes reduce the near-term likelihood of a qualifying new designation before year-end.

Odds sourced live from Polymarket, refreshed through the day. Prediction-market participation carries risk and may be restricted in your jurisdiction. Informational only — not investment advice.